BDX Becton, Dickinson and Co. SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Best Medical Devices Stocks 2026 →

Becton, Dickinson and (BDX) Stock: Buy, Sell, or Hold?

$212.61
-2.64 (-1.23%) ▼
5d: +7.29% 30d: +12.56% 90d: +15.81%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (23%)
Quality Score
37/100
Position
EXTENDED
30-Day Fair Range
$184.39 – $205.28
Position: EXTENDED
Forward P/E & Valuation
16.0x STRETCHED
vs 12.6x historical avg
Wall Street Target
$224.00
+5.4% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$193.80 / $216.74
Trend: Strong Uptrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: BDX shows conflicting indicators. Wait for confirmation before entering.

Get Alerted When BDX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$208.86
Based on 4.5% avg growth
INTRINSIC VALUE TODAY
$129.68
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.6x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: BDX is currently trading at $212.61, which is considered extended relative to its 30-day fair value range of $184.39 to $205.28. From a valuation perspective, the stock is trading at a premium (Forward PE: 16.0) compared to its historical average (12.6). At these levels, the market is pricing in 8.3% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, BDX is in a strong uptrend. The price is approaching resistance at $216.74. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: BDX scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $184.39 - $205.28
Company Quality Score 37/100 (SELL)
Volume Confirmation HIGH
Confidence Score 22.9%

Trading Range & Key Levels

30-Day Trading Range $184.39 - $205.28
Current vs Trading Range EXTENDED
Support Level $193.80
Resistance Level $216.74
Current Trend Strong Uptrend
Technical data as of Nov 10, 2026

Protect Your Profits

BDX is technically overbought (RSI 71). Consider hedging now to protect against a potential pullback while keeping your upside.

View Profit Protection Plan

Quantitative Signal Breakdown

  • BEARISH: Price extended above range
  • BEARISH: Weak technical setup (0/100)
  • BULLISH: High volume confirmation
  • NEUTRAL: Near Wall St target ($224.00)
  • NEUTRAL: Trading at premium valuation - market expects 8.3% growth which is achievable
  • WARNING: Composite score 36/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) 15.98
Wall Street Target $224.00 (+5.4%)
Revenue Growth (YoY) -10.5%
Earnings Growth (YoY) 47.6%
Profit Margin 5.9%
Valuation Premium vs History +8.3% premium
PE vs Historical 16.0 vs 12.6 STRETCHED
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +8.3% (market-implied from PE analysis)
1-Year Target $230.26 (+8%)
2-Year Target $249.37 (+17%)
3-Year Target $270.07 (+27%)
3-Yr Target (if PE normalizes) (PE: 16→13) PE COMPRESSION $212.89 (+0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 19.9, Growth: 5.0%) $305.49 (+44%)
Base: (SPY PE: 16.0, Growth: 5.0%) $245.87 (+16%)
Bear: (PE: 12.6, Growth: 5.0%) $193.82 (-9%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (43x PE), but valuation improves significantly next year (16x PE) as earnings recover.
Trailing PE: 42.54 | Current EPS (TTM): $5.06
Bull Case $473.55 (+123%)
Analyst growth 100.0%, PE expands to 46.8
Base Case $430.50 (+103%)
Market implied 100.0%, PE stable at 42.5
Bear Case $146.37 (-31%)
Severe decline -20.0%, PE contracts to 36.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share BDX Analysis

Share this live BDX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (BDX)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 21, 2026
Daily AI digest
AI Retail Discussion Summary: Stocks rebounded on Wednesday as investors bought back into non-tech names after a tech-led decline in the previous session. Becton Dickinson ($BDX) broke out of a technical pattern, according to one trader on StockTwits.
Key Retail Themes: Market rebound Technical analysis
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 10, 2026 9:20 PM ET
Data refreshes hourly during market hours. Next update: 10:20 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for BDX.

Create Free Account

Already have an account? Log In

Top Rated Medical Instruments & Supplies Stocks

Top-rated stocks in Medical Instruments & Supplies by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ISRG
Intuitive Surgical Inc
STRONG BUY
34 analysts
$486 39 SELL
RGEN
Repligen Corporation
STRONG BUY
21 analysts
$203 65 BUY
ALC
Alcon AG
STRONG BUY
27 analysts
$82 27 SELL
WST
West Pharmaceutical Serv…
STRONG BUY
16 analysts
$471 52 HOLD
RMD
ResMed Inc
HOLD
20 analysts
$264 52 HOLD

Advanced BDX Option Strategies

Professional options setups generated by AI based on today's BDX price and gamma walls.

Iron Condor Bull Call Bear Put Collar

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive BDX Research Pages
BDX Technical Chart BDX Price Prediction BDX Intrinsic Value DCF BDX Earnings Date BDX Investment Advisor BDX Fair Price Analyzer BDX Options Chain BDX Options Advisor BDX Options Analysis BDX Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals